forecast
mRNA platforms allow de-risking before clinical entry
mRNA technology is a powerful platform because developers can rapidly prototype candidates and reduce risk before entering clinical trials, although trials still take time.
forecastpending
Speaker
Mark SmithEvidence Quote
“knowing what you want to target and being able to heavily de-risk that before you get into the clinic is a really interesting technological platform.”
Created: 11/16/2026, 7:13:42 PM
Your notes
Loading notes...